Ovarian Function Suppression With Luteinizing Hormone-Releasing Hormone Agonists for the Treatment of Hormone Receptor-Positive Early Breast Cancer in Premenopausal Women.

Lu, Yen-Shen; Wong, Andrea; Kim, Hee-Jeong

Lu, Yen-Shen; Wong, Andrea; Kim, Hee-Jeong.

Afiliação

Lu YS; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
Wong A; Department of Haematology-Oncology, Cancer Science Institute, National University of Singapore, Singapore, Singapore.
Kim HJ; Department of Surgery, College of Medicine, Asan Medical Center, Seoul, South Korea.

Front Oncol ; 11: 700722, 2021.

Article em En | MEDLINE | ID: mdl-34595110

Palavras-chave

breast cancer; endocrine therapy; luteinizing hormone releasing hormone; ovarian function preservation; ovarian function suppression (OFS); premenopausal

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google